For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...

So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...

Within Urology, Boston Scientific continues to expand its market share globally. The company’s stone management and prosthetic urology franchises are growing well, led by the strong performances ...

Boston Scientific Corp (BSX) reports impressive Q4 2024 results with 22.4% revenue growth and a 26% increase in adjusted EPS, ...

Truist analyst Richard Newitter raised the firm’s price target on Boston Scientific (BSX) to $120 from $110 and keeps a Buy rating on the ...

Urology led the way with a 19.5% increase. Neuromodulation (+11.4%) and Endoscopy (7%) followed. Outlook: Boston Scientific forecasts net sales growth of approximately 12.5%-14.5% in 2025 on a ...

The University of Arkansas for Medical Sciences (UAMS) has been designated the state’s only Center of Excellence for ...

Boston Scientific Corp. engages in the development ... The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral ...

Boston Scientific apparently knows a good bet when it sees one. | That includes treating more than 200,000 patients with the irregular heartbeat known as atrial fibrillation—and the sum more than ...